Compare
Up to four compounds, side by side.
Useful for choosing between similar peptides or planning a stack.
Add a peptide
| Attribute | Immune Modulator VIP |
|---|---|
| Summary | Used off-label in CIRS/mold-illness protocols. |
| Mechanism | Activates VPAC1/VPAC2 receptors with broad immunomodulatory and vasodilatory effects. |
| Top outcomes |
|
| Evidence | emerging |
| Half-life | ~2 minutes (extended via nasal carrier) |
| Administration | nasal, subq |
| Legal status | rx only |
| Safety | Flushing, BP changes, GI effects possible. |